Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy

Lymphocyte depletion chemotherapy CD19-targeted chimeric antigen receptor-modified T (CAR-T) cell immunotherapy is an innovative approach for the treatment of refractory or relapsed B-cell malignancies. This method also has the occurrence of infection, and there has been no systematic analysis of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhilin, Lian, Yu, Ti, Juanjuan, Ren, Ruirui, Ma, Liangming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997630/
https://www.ncbi.nlm.nih.gov/pubmed/36728516
http://dx.doi.org/10.1097/CAD.0000000000001485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997630/
https://www.ncbi.nlm.nih.gov/pubmed/36728516
http://dx.doi.org/10.1097/CAD.0000000000001485

Ejemplares similares